cytarabine has been researched along with Dupre Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumhefner, RW; Ma, BI; Mendez, M; Potvin, AR; Potvin, JH; Syndulko, K; Tourtellotte, WW | 1 |
| Grisold, W; Lutz, D; Mamoli, B; Mokrusa, W; Weber, R | 1 |
2 other study(ies) available for cytarabine and Dupre Syndrome
| Article | Year |
|---|---|
Failure of intravenous and intrathecal cytarabine to modify central nervous system IgG synthesis in multiple sclerosis.
Topics: Adult; Central Nervous System; Cytarabine; Female; Hemianopsia; Humans; Immunoglobulin G; Injections, Intravenous; Injections, Spinal; Male; Meningism; Middle Aged; Multiple Sclerosis | 1980 |
[Acute myelomonocytic and monoblastic leukemia with polyradicular symptoms].
Topics: Abducens Nerve; Adult; Aminoglutethimide; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cerebral Hemorrhage; Cerebrospinal Fluid; Cranial Nerve Diseases; Cytarabine; Danazol; Demyelinating Diseases; Facial Paralysis; Female; Humans; Leukemia, Monocytic, Acute; Leukemia, Myeloid, Acute; Meningism; Methotrexate; Middle Aged; Spinal Nerve Roots; Tamoxifen | 1985 |